Journals / Üroonkoloji Bülteni / 2020 / Cilt: 19 - Sayı: 2

Evaluation of Histopathologic Results of Testicular Tumors in Antalya: Multi Center Study

Pages
64–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, our findings suggest that urologists feel hesitant to practice testis-sparing surgery despite recommendations in international guidelines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Testicular tumors constitute 1% of all malignancies in men.
📊
Key Findings & Data:Materials and Methods: In this descriptive multicenter study, we evaluated the histopathologic results of 124 patients who underwent radical or partial orchiectomy with a diagnosis of testicular tumor between 2011 and 2019 in the region of Antalya, Turkey.
💡
Conclusion & Impact:In addition, our findings suggest that urologists feel hesitant to practice testis-sparing surgery despite recommendations in international guidelines.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Testicular tumors constitute 1% of all malignancies in men. Being a relatively uncommon tumor, there are few descriptive studies in the literature. The aim of this study is to retrospectively investigate the histopathological results of testicular tumors in our region. aim of this study is to retrospectively investigate the histopathological results of testicular tumors in our region. Materials and Methods: In this descriptive multicenter study, we evaluated the histopathologic results of 124 patients who underwent radical or partial orchiectomy with a diagnosis of testicular tumor between 2011 and 2019 in the region of Antalya, Turkey. All specimens were examined by the pathologists in a single center. Data pertaining to patient age, type of operation, histopathological tumor type, tumor size, and pathological stage of the primary tumor (pT) were analyzed. Results: The mean age of the 124 patients included in the study was 35.14±15.3 (2-80) years. Most (98.4%) of the analyzed specimens were radical orchiectomy materials, while only 1.6% were partial orchiectomy materials. Mean tumor size was 4.01±2.29 (0.5-11) cm. Tumor size was ≤2 cm in 29 (23.4%) specimens and ≥2 cm in 95 (76.6%) specimens. In terms of histopathology, 76.8% were germ cell tumors, 6.4% were gender cord-stromal tumors, 4.8% were ductal canal and rete testis tumors, and 12% were secondary tumors of the testis. Pathological stage of the pT was pT1 in 46%, pT2 in 39%, and pT3 in 15% of the patients. Conclusion: Although patient age and histopathological distribution of testicular tumors were generally consistent with the literature, the average tumor size in the orchiectomy materials was notably large. Initiatives are required to increase public awareness of the importance of early detection. In addition, our findings suggest that urologists feel hesitant to practice testis-sparing surgery despite recommendations in international guidelines.

🔖

Cite This Article

SARIER, M., TUNÇ, M., ÖZEL, E., DUMAN, İ., KAYA, S., HOŞCAN, M. B., ISGOREN, E., YÜCE, A., BULUT, K., ÜNSAL, Ç. (2020). Evaluation of Histopathologic Results of Testicular Tumors in Antalya: Multi Center Study. Üroonkoloji Bülteni, Cilt: 19 - Sayı: 2, 64–67. https://ajindex.com/articles/334419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359-386
  2. Cheng L, Albers P, Berney DM, et al. Testicular cancer. Nat Rev Dis Prim 2018;4:29
  3. Ghazarian AA, Kelly SP, Altekruse SF, Rosenberg PS, McGlynn KA. Future of testicular germ cell tumor incidence in the United States: Forecast through 2026. Cancer 2017;123:2320-2328
  4. Albers P, Albrecht W, Algaba F, Al E. European Association of Urology, Guidelines on Testicular Cancer 2018
  5. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol 2016;70:93-105
  6. Magers MJ, Idrees MT. Updates in Staging and Reporting of Testicular Cancer. Surg Pathol Clin 2018;11:813-824
  7. Aparicio J. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited. Clin Transl Oncol. 2018;20:1358-1359
  8. Boormans JL, Mayor de Castro J, Marconi L, et al. Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel. Eur Urol 2018;73:394-405
  9. Oztekin S. Testisin Germ Hücreli Tümörlerinde Fas, FasL, ve p27 ekspresyonu: Histopatolojik alt tiplerine göre ve erişkinde normal testis dokusu ile karşılaştırılması. Akdeniz Univ. 2001
  10. Djaladat H. Organ-sparing surgery for testicular tumours. Curr Opin Urol 2015;25:116-120
  11. Keske M, Canda AE, Atmaca AF, et al. Testis-sparing surgery: Experience in 13 patients with oncologic and functional outcomes. Can Urol Assoc J 2018;13:83-88
  12. Stephenson A, Eggener SE, Bass EB, et al. Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. J Urol 2019;202:272-281
  13. Alanee S, Clemons J, Holland B, Nutt M, Dynda D. The Utilization of Partial Orchiectomy in Treating Small Testicular Tumors in the United States. Int J Cancer Clin Res 2017;4:1-7
  14. Kuzgunbay B, Yaycioglu O, Soyupak B, et al. Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society. Urol Oncol Semin Orig Investig 2013;31:386-391
  15. Ulbright TM, Young RH. Metastatic Carcinoma to the Testis. Am J Surg Pathol 2008;32:1683-1693
  16. Dutt N, Bates AW, Baithun SI. Secondary neoplasm